{"id":"group-t","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Headache"},{"rate":"5-10%","effect":"Dizziness"},{"rate":"5-10%","effect":"Nausea"}]},"_chembl":null,"_dailymed":{"setId":"4d8781ff-9366-462c-8161-6e958f44fcb4","title":"MENACTRA (NEISSERIA MENINGITIDIS GROUP A CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP C CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN, NEISSERIA MENINGITIDIS GROUP Y CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN, AND NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR POLYSACCHARIDE DIPHTHERIA TOXOID CONJUGATE ANTIGEN) INJECTION, SOLUTION [SANOFI VACCINES US INC.]"},"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This inhibition leads to a decrease in the production of a certain compound, resulting in therapeutic effects. The exact mechanism is complex and involves multiple pathways.","oneSentence":"Group T works by inhibiting the action of a specific enzyme.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:14:26.787Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Hypertension"}]},"trialDetails":[{"nctId":"NCT07498829","phase":"NA","title":"Population Based Germline Testing for Early Detection and Prevention of Cancer","status":"RECRUITING","sponsor":"Queen Mary University of London","startDate":"2025-12-18","conditions":"Breast Cancer Risk, Ovarian Cancer Risk, Cancer Gene Mutation","enrollment":6000},{"nctId":"NCT00980460","phase":"PHASE3","title":"Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2009-09-14","conditions":"PRETEXT I Hepatoblastoma, PRETEXT II Hepatoblastoma, PRETEXT III Hepatoblastoma","enrollment":236},{"nctId":"NCT07495215","phase":"PHASE1, PHASE2","title":"A Clinical Study on the Safety, Tolerability and Efficacy of Neoantigen-based Personalized mRNA Therapy iNeo-Vac-R01 Plus PD-1 Inhibitor in Adjuvant Treatment of Liver Cancer Post Radical Resection","status":"RECRUITING","sponsor":"Yinghua Xu","startDate":"2025-09-11","conditions":"Hepatocellular Carcinoma (HCC)","enrollment":20},{"nctId":"NCT01846390","phase":"PHASE1","title":"Romidepsin, Gemcitabine, Dexamethasone and Cisplatin in the Treatment of Peripheral T-Cell and Diffuse Large B-Cell Lymphoma","status":"COMPLETED","sponsor":"Canadian Cancer Trials Group","startDate":"2013-10-01","conditions":"Peripheral T-Cell Lymphoma, Diffuse Large B-Cell Lymphoma","enrollment":21},{"nctId":"NCT06904066","phase":"PHASE1","title":"Autologous T Cells Transduced With Retroviral Vectors Expressing TCRs for Participant-specific Neoantigens in Patients With Hematologic Malignancies","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-04-01","conditions":"Malignancy, Hematologic, Neoplasms, Hematologic, Neoplasms, Hematopoietic","enrollment":86},{"nctId":"NCT07489157","phase":"NA","title":"Real-Time End-Tidal Carbon Dioxide Monitoring for Early Warning of Hypoxemia in Painless Gastrointestinal Endoscopy","status":"NOT_YET_RECRUITING","sponsor":"Chinese PLA General Hospital","startDate":"2026-03-27","conditions":"Hypoxemia","enrollment":460},{"nctId":"NCT05463133","phase":"PHASE1, PHASE2","title":"Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease (CGD) With an Alemtuzumab, Busulfan and TBI-based Conditioning Regimen Combined With Cytokine (IL-6, +/- IFN-gamma) Antagonists","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2022-07-08","conditions":"Chronic Granulomatous Disease","enrollment":50},{"nctId":"NCT03017820","phase":"PHASE1","title":"A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2017-04-04","conditions":"B-Cell Non-Hodgkin Lymphoma, Histiocytic and Dendritic Cell Neoplasm, Myelodysplastic Syndrome","enrollment":127},{"nctId":"NCT06179888","phase":"PHASE2","title":"Iberdomide Versus Observation Off Therapy After Idecabtagene Vicleucel CAR-T for Multiple Myeloma","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-08-27","conditions":"Multiple Myeloma","enrollment":78},{"nctId":"NCT05514327","phase":"NA","title":"A Study of Ultra-fraction Radiotherapy Bridging CART in R/R DLBCL","status":"RECRUITING","sponsor":"Peking Union Medical College Hospital","startDate":"2022-09-01","conditions":"Diffuse Large B Cell Lymphoma, CAR-T, Radiotherapy","enrollment":20},{"nctId":"NCT06314334","phase":"PHASE2","title":"Screening Study of Combined Sequential Chemotherapy and Radiation Therapy for Early-stage NK/T-cell Lymphoma","status":"RECRUITING","sponsor":"Fudan University","startDate":"2024-03-04","conditions":"Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type","enrollment":210},{"nctId":"NCT06799247","phase":"PHASE3","title":"Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia Gravis","status":"RECRUITING","sponsor":"Cartesian Therapeutics","startDate":"2025-05-06","conditions":"Myasthaenia Gravis","enrollment":100},{"nctId":"NCT07151690","phase":"PHASE2","title":"BCMA/CD3 Bispecific Antibody Treatment for Newly Diagnosed Amyloidosis","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2025-09-04","conditions":"Systemic Light Chain Amyloidosis","enrollment":21},{"nctId":"NCT06937684","phase":"NA","title":"Early Oral Fluid Intake in Children After Day Surgery","status":"COMPLETED","sponsor":"Ankara City Hospital Bilkent","startDate":"2024-11-01","conditions":"Pediatric Anesthesia, Postoperative Nausea and Vomiting (PONV), Ambulatory Surgical Procedures","enrollment":172},{"nctId":"NCT02287311","phase":"PHASE1","title":"Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Baylor College of Medicine","startDate":"2015-02","conditions":"Hodgkin Disease, Non-Hodgkin Lymphoma, Severe Chronic Active Epstein Barr Virus","enrollment":38},{"nctId":"NCT06958731","phase":"NA","title":"In-plane Versus Real Time Bi-plane Single-operator Laser-assisted With a Innovative T-shaped Probe for Ultrasound-guided Internal Jugular Vein Catheterization:A Randomized Controlled Trial","status":"ENROLLING_BY_INVITATION","sponsor":"The First Hospital of Jilin University","startDate":"2026-01-12","conditions":"Catheterization, Central Venous, Ultrasound Guided","enrollment":352},{"nctId":"NCT06494033","phase":"","title":"Prophylaxis Guided by Cytomegalovirus-specific T Cell Immunity to Prevent Cytomegalovirus Disease in Lung Transplant Recipients","status":"RECRUITING","sponsor":"University of Miami","startDate":"2024-07-03","conditions":"Lung Diseases","enrollment":100},{"nctId":"NCT00338377","phase":"PHASE2","title":"Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic Melanoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2006-02-01","conditions":"Melanoma","enrollment":1230},{"nctId":"NCT02016924","phase":"PHASE2, PHASE3","title":"Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV","status":"ACTIVE_NOT_RECRUITING","sponsor":"Gilead Sciences","startDate":"2014-01-16","conditions":"Acquired Immune Deficiency Syndrome (AIDS), HIV Infections","enrollment":133},{"nctId":"NCT07015697","phase":"PHASE1","title":"A Study of Subcutaneous Trastuzumab Deruxtecan in Participants With Metastatic Solid Tumors","status":"RECRUITING","sponsor":"Daiichi Sankyo","startDate":"2025-07-17","conditions":"Recurrent or Metastatic Solid Tumors","enrollment":76},{"nctId":"NCT07380984","phase":"PHASE2","title":"PD-1 Antibody-based Therapy With Concurrent RT for Early-stage NKTCL","status":"RECRUITING","sponsor":"Ruijin Hospital","startDate":"2026-03","conditions":"Natural Killer/T-cell Lymphoma","enrollment":47},{"nctId":"NCT07483840","phase":"NA","title":"Analgesic Techniques for Robotic Prostatectomy Procedures","status":"NOT_YET_RECRUITING","sponsor":"Ente Ospedaliero Ospedali Galliera","startDate":"2026-07-01","conditions":"Postoperative Analgesia","enrollment":147},{"nctId":"NCT06624514","phase":"NA","title":"mHealth Behavior Study","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2025-01-29","conditions":"Alcohol Consumption, Condom Use","enrollment":46},{"nctId":"NCT07350863","phase":"PHASE1","title":"U69-CART-Cells For R/R T-ALL","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Soochow University","startDate":"2026-06-25","conditions":"Relapsed/Refractory T-lymphoblastic Leukemia/Lymphoma","enrollment":12},{"nctId":"NCT02789228","phase":"PHASE1","title":"Research Study Utilizing Expanded Multi-antigen Specific Lymphocytes for the Treatment of Solid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's National Research Institute","startDate":"2016-10-12","conditions":"Solid Tumors","enrollment":28},{"nctId":"NCT05879965","phase":"","title":"Prospective Study for the FOLLOW-UP of Human Monkeypox Cases and Smallpox Vaccinees at Risk","status":"RECRUITING","sponsor":"Institute of Tropical Medicine, Belgium","startDate":"2022-10-06","conditions":"Monkeypox","enrollment":345},{"nctId":"NCT07066813","phase":"","title":"Staging Strategies and Their Association With Prognosis and Therapy in Lung Cancer With Cystic Airspaces","status":"RECRUITING","sponsor":"Central South University","startDate":"2025-06-01","conditions":"Lung Cancer Associated With Cystic Airspaces","enrollment":500},{"nctId":"NCT06552286","phase":"NA","title":"STRW-T Intervention for Autistic Adolescents in 11th and 12th Grade","status":"RECRUITING","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2024-07-10","conditions":"Autism Spectrum Disorder","enrollment":192},{"nctId":"NCT07461415","phase":"NA","title":"Coaching and Navigation by Community Health Workers (CHWs) Through Telehealth for High-risk Hypertension","status":"RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2026-03-16","conditions":"Hypertension","enrollment":3620},{"nctId":"NCT06621472","phase":"NA","title":"Retrolaminar Block Versus Subcostal Transversus Abdominis Plane Block in Liver Resection Surgery","status":"RECRUITING","sponsor":"Cairo University","startDate":"2024-10-01","conditions":"Cancer Liver","enrollment":90},{"nctId":"NCT07479927","phase":"NA","title":"Telematic Cognitive Training and Mindfulness in Pediatric Patients After CAR-T Cell Therapy, Single Hematopoietic Allogeneic Transplant or Chemotherapy","status":"RECRUITING","sponsor":"Hospital Universitario La Paz","startDate":"2025-12-19","conditions":"Acute Lymphoblastic Leukemia","enrollment":40},{"nctId":"NCT07413835","phase":"NA","title":"Efficacy and Safety of HN2302 in Refractory Myasthenia Gravis(MG)","status":"RECRUITING","sponsor":"The Affiliated Hospital of Xuzhou Medical University","startDate":"2026-03-17","conditions":"Refractory Myasthenia Gravis","enrollment":6},{"nctId":"NCT06207123","phase":"PHASE1, PHASE2","title":"A Study to Investigate LP-118, Ponatinib, Vincristine and Dexamethasone in Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL)","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2024-09-13","conditions":"Acute Leukemia, Lymphoblastic Leukemia, Lymphoblastic Lymphoma","enrollment":15},{"nctId":"NCT07444229","phase":"NA","title":"Team-Based Learning Integrated Into Clinical Simulation in Nursing Students","status":"NOT_YET_RECRUITING","sponsor":"University of Pisa","startDate":"2026-03-01","conditions":"Nursing Education","enrollment":150},{"nctId":"NCT07478562","phase":"NA","title":"Thoracolumbar Fascia","status":"COMPLETED","sponsor":"Gaziantep Islam Science and Technology University","startDate":"2025-02-15","conditions":"Exercise, Fascial Mobilization","enrollment":51},{"nctId":"NCT05323955","phase":"PHASE2","title":"Secondary BRain Metastases Prevention After Isolated Intracranial Progression on Trastuzumab/Pertuzumab or T-DM1 in Patients With aDvanced Human Epidermal Growth Factor Receptor 2+ brEast Cancer With the Addition of Tucatinib","status":"ACTIVE_NOT_RECRUITING","sponsor":"Carey Anders, M.D.","startDate":"2023-03-23","conditions":"Brain Metastases, Human Epidermal Growth Factor 2 Positive Carcinoma of Breast, Advanced Breast Cancer","enrollment":48},{"nctId":"NCT05909527","phase":"PHASE1, PHASE2","title":"A Clinical Study of CAR-T Treating Relapsed or Refractory T Cell Lymphoblastic Acute Leukemia/ Lymphoma","status":"WITHDRAWN","sponsor":"Guangzhou Bio-gene Technology Co., Ltd","startDate":"2023-05-01","conditions":"T-Cell Acute Lymphocytic Leukemia","enrollment":""},{"nctId":"NCT07478276","phase":"NA","title":"PulmoSalud: Multimodal Program for Prehabilitation and Early Home Rehabilitation in Patients With Lung Cancer","status":"NOT_YET_RECRUITING","sponsor":"FranciscoVeraSerrano","startDate":"2028-01","conditions":"Lung Cancer","enrollment":84},{"nctId":"NCT04133636","phase":"PHASE2","title":"A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2019-11-07","conditions":"Multiple Myeloma","enrollment":210},{"nctId":"NCT07451210","phase":"NA","title":"Evaluating the Efficacy of Blood Flow Restriction Therapy in a Randomized Clinical Trial for Postoperative Rehabilitation Following Ankle Ligament Reconstruction","status":"RECRUITING","sponsor":"Texas Tech University Health Sciences Center","startDate":"2026-03-01","conditions":"Ankle Reconstruction, Blood Flow Restriction Therapy, Physical Therapy","enrollment":105},{"nctId":"NCT06848504","phase":"NA","title":"MedSMA℞T Mobile ED","status":"NOT_YET_RECRUITING","sponsor":"Olufunmilola Abraham","startDate":"2026-09","conditions":"Opiate-Related Disorders, Opiate Use Disorder, Opioid","enrollment":244},{"nctId":"NCT06859424","phase":"PHASE2","title":"A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation","status":"RECRUITING","sponsor":"Center for International Blood and Marrow Transplant Research","startDate":"2025-07-25","conditions":"AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL), Acute Leukemia (Category)","enrollment":358},{"nctId":"NCT07476729","phase":"PHASE3","title":"International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)","status":"NOT_YET_RECRUITING","sponsor":"Charite University, Berlin, Germany","startDate":"2026-04-01","conditions":"B-Cell Acute Lymphoblastic Leukaemia","enrollment":750},{"nctId":"NCT07473310","phase":"PHASE4","title":"Low-intensity Shockwave Therapy Versus Solifenacin for the Treatment of Overactive Bladder in Women","status":"RECRUITING","sponsor":"Mansoura University","startDate":"2025-11-11","conditions":"Overactive Bladder (OAB), Urge Incontinence","enrollment":70},{"nctId":"NCT07061574","phase":"PHASE1, PHASE2","title":"A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2026-03-30","conditions":"Type 1 Diabetes, New Onset","enrollment":120},{"nctId":"NCT07466368","phase":"NA","title":"The Effects of Manipulation on Pain, Quality of Life, and Functional Activity in People Who Practice Pilates.","status":"COMPLETED","sponsor":"Istanbul Rumeli University","startDate":"2025-04-10","conditions":"Manipulation, Osteopathic, Pilates Exercise, Non-specific Spinal Problems","enrollment":43},{"nctId":"NCT06508463","phase":"PHASE1","title":"Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2024-01-05","conditions":"Peripheral T Cell Lymphoma, Relapsed Peripheral T-Cell Lymphoma, Peripheral T-Cell Lymphoma, Not Otherwise Specified","enrollment":21},{"nctId":"NCT06109766","phase":"NA","title":"Delivering Evidence-Based Parenting Services to Families in Child Welfare Using Telehealth","status":"RECRUITING","sponsor":"University of Washington","startDate":"2023-10-12","conditions":"Parenting, Parent-Child Relations, Child Behavior","enrollment":357},{"nctId":"NCT06555393","phase":"PHASE1","title":"Understanding the Health Effect of a Bioactive Peptide From Egg: A Pilot Study","status":"RECRUITING","sponsor":"University of Alberta","startDate":"2026-02-25","conditions":"High Blood Sugar, High Blood Pressure, Overweight and Obesity","enrollment":28},{"nctId":"NCT06200467","phase":"PHASE1","title":"A Study to Test Whether Multiple Doses of BI 456906 Have an Effect on Cardiac Safety in People With Overweight or Obesity","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2024-03-13","conditions":"Overweight, Obesity","enrollment":110},{"nctId":"NCT06019949","phase":"NA","title":"Spinal Cord Stimulation for Respiratory Rehabilitation in Patients With Chronic Spinal Cord Injury","status":"RECRUITING","sponsor":"University of Louisville","startDate":"2023-09-10","conditions":"Spinal Cord Injuries, Respiration Disorders","enrollment":36},{"nctId":"NCT07471815","phase":"PHASE2","title":"Camrelizumab Plus Risedronate and Chemotherapy for Triple-Negative Breast Cancer: An Exploratory Clinical Study on Mechanisms and Efficacy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Harbin Medical University","startDate":"2026-03-04","conditions":"Breast Cancer Triple Negative Breast Cancer","enrollment":30},{"nctId":"NCT07470151","phase":"NA","title":"Clinical Study of EVM18001 in the Treatment of Refractory Autoimmune Diseases","status":"RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2026-03-12","conditions":"System Lupus Erythematosus(SLE), Scleroderma, Myasthenia Gravis (MG)","enrollment":12},{"nctId":"NCT06875063","phase":"PHASE1","title":"GB5005 CART-cell Injection in the Treatment of Patients With CD19-positive RR B-NHL","status":"RECRUITING","sponsor":"The First Affiliated Hospital of Xiamen University","startDate":"2026-04-30","conditions":"Non-hodgkin Lymphoma, Refractory Lymphoma, Chimeric Antigen Receptor T-cell","enrollment":45},{"nctId":"NCT05417594","phase":"PHASE1, PHASE2","title":"Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies","status":"RECRUITING","sponsor":"AstraZeneca","startDate":"2022-06-24","conditions":"Advanced Solid Malignancies","enrollment":695},{"nctId":"NCT05123443","phase":"","title":"Longitudinal Assessment of Iron Rims in MS Lesions","status":"RECRUITING","sponsor":"Nottingham University Hospitals NHS Trust","startDate":"2022-09-03","conditions":"Multiple Sclerosis","enrollment":100},{"nctId":"NCT07461831","phase":"PHASE2","title":"CD19/ CD22 Bispecific CAR-T Cell Therapy for Relapsed/ Refractory Large B-cell Lymphoma","status":"RECRUITING","sponsor":"Beijing Tongren Hospital","startDate":"2022-02-01","conditions":"Large B-Cell Lymphoma (LBCL)","enrollment":100},{"nctId":"NCT05926024","phase":"","title":"Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary Treatment","status":"ACTIVE_NOT_RECRUITING","sponsor":"UNC Lineberger Comprehensive Cancer Center","startDate":"2023-01-06","conditions":"Breast Cancer","enrollment":253},{"nctId":"NCT07448298","phase":"EARLY_PHASE1","title":"A Clinical Study of AFN50 in the Treatment of Autoimmune Diseases","status":"RECRUITING","sponsor":"Beijing Boren Hospital","startDate":"2026-03-09","conditions":"Relapsed/Refractory Autoimmune Diseases","enrollment":18},{"nctId":"NCT07461181","phase":"PHASE1, PHASE2","title":"A Study to Evaluate the Safety, Tolerability, PK, PD, and Preliminary Efficacy of CS01 in Patients With Locally Advanced or Metastatic Solid Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"Ruijin Hospital","startDate":"2024-12-30","conditions":"Locally Advanced or Metastatic Solid Tumors","enrollment":10},{"nctId":"NCT06193759","phase":"PHASE1","title":"Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)","status":"RECRUITING","sponsor":"Children's National Research Institute","startDate":"2024-09-20","conditions":"Medulloblastoma, Childhood, Atypical Teratoid/Rhabdoid Tumor of CNS, Embryonal Tumor With Multilayered Rosettes","enrollment":12},{"nctId":"NCT07173166","phase":"NA","title":"Non-Pharmacological Interventions for Neurotoxicity in Hematologic Patients Receiving CAR-T Therapy","status":"RECRUITING","sponsor":"Instituto de Investigacion Sanitaria INCLIVA","startDate":"2025-09-30","conditions":"Hematologic Cancer","enrollment":100},{"nctId":"NCT06326021","phase":"PHASE1","title":"Optimised CD33 (FL-33) CAR T Therapy for Refractory/Relapsed Acute Myeloid Leukaemia","status":"RECRUITING","sponsor":"Beijing GoBroad Hospital","startDate":"2024-04-02","conditions":"Refractory/Relapsed Acute Myeloid Leukaemia","enrollment":27},{"nctId":"NCT05208892","phase":"NA","title":"Dexmedetomidine Use in SZMN Blocks for Pediatric T&A Pain Control","status":"COMPLETED","sponsor":"Stanford University","startDate":"2024-01-29","conditions":"Postoperative Pain, Opioid Use","enrollment":114},{"nctId":"NCT05514132","phase":"PHASE1","title":"A Study to Evaluate the Safety and Pharmacokinetics of Ceralasertib in Combination With Durvalumab in Chinese Patients With Advanced Solid Tumours","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2022-09-23","conditions":"Advanced Solid Tumours","enrollment":14},{"nctId":"NCT06192979","phase":"NA","title":"Optimize First-line Treatment for AL Amyloidosis With t (11; 14)","status":"RECRUITING","sponsor":"Jin Lu, MD","startDate":"2024-01-05","conditions":"Amyloidosis; Systemic, AL Amyloidosis","enrollment":41},{"nctId":"NCT07454005","phase":"NA","title":"Innovative Probe With Laser on Radial Artery Puncture and Catheterisation in Paediatric","status":"ENROLLING_BY_INVITATION","sponsor":"The First Hospital of Jilin University","startDate":"2026-02-11","conditions":"Radial Artery Catheterization, Paediatric, Ultrasound Guided","enrollment":360},{"nctId":"NCT04940299","phase":"PHASE2","title":"Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2021-09-23","conditions":"Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Bladder Carcinoma","enrollment":35},{"nctId":"NCT07456371","phase":"PHASE1","title":"PIC1 Injection Therapy for Relapsed/Refractory B-NHL","status":"RECRUITING","sponsor":"Chongqing Precision Biotech Co., Ltd","startDate":"2026-03","conditions":"Non-Hodgkin Lymphoma","enrollment":18},{"nctId":"NCT07456449","phase":"NA","title":"Collagen Peptides and Cellular Aging","status":"NOT_YET_RECRUITING","sponsor":"University of Vienna","startDate":"2026-02","conditions":"Longevity, Healthy Aging, Biological Ageing","enrollment":125},{"nctId":"NCT07454226","phase":"NA","title":"ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL","status":"NOT_YET_RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2026-03-01","conditions":"Ph-Like, Acute Lymphoblastic Leukemia","enrollment":30},{"nctId":"NCT06475495","phase":"PHASE1, PHASE2","title":"Comparison of B-cell Depletion by Rituximab and Anti-CD 19 CAR-T Therapy in Patients With Rheumatoid Arthritis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Charite University, Berlin, Germany","startDate":"2024-12-04","conditions":"Rheumatoid Arthritis","enrollment":13},{"nctId":"NCT07408336","phase":"EARLY_PHASE1","title":"Clinical Study of AFN50 Injection in the Autoimmune Diseases","status":"RECRUITING","sponsor":"AlphaNa Bioscience Company Limited","startDate":"2026-02-04","conditions":"Autoimmune Diseases","enrollment":18},{"nctId":"NCT07371104","phase":"PHASE1","title":"Bioequivalence Study of DWZ2501 in Patients With Advanced BRCA-mutated High-grade Ovarian Cancer","status":"RECRUITING","sponsor":"Daewoong Pharmaceutical Co. LTD.","startDate":"2026-02-20","conditions":"Cancer, Ovarian Cancer","enrollment":40},{"nctId":"NCT03849651","phase":"PHASE2","title":"TCRαβ-depleted Progenitor Cell Graft With Additional Memory T-cell DLI, Plus Selected Use of Blinatumomab, in Naive T-cell Depleted Haploidentical Donor Hematopoietc Cell Transplantation for Hematologic Malignancies","status":"ACTIVE_NOT_RECRUITING","sponsor":"St. Jude Children's Research Hospital","startDate":"2019-01-31","conditions":"Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)","enrollment":69},{"nctId":"NCT05586360","phase":"PHASE2","title":"T-reg Function Changes: a Novel Immune Regulatory Effect Underlying Benefit of Statin Use on Lethal Prostate Cancer","status":"RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2024-03-11","conditions":"Prostate Cancer","enrollment":36},{"nctId":"NCT05866757","phase":"NA","title":"Discontinuation Study","status":"RECRUITING","sponsor":"University College Cork","startDate":"2023-08-28","conditions":"Multiple Myeloma, Cancer, Hematologic Cancer","enrollment":70},{"nctId":"NCT07236762","phase":"PHASE1","title":"An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases","status":"RECRUITING","sponsor":"China Immunotech (Beijing) Biotechnology Co., Ltd.","startDate":"2025-11-24","conditions":"Systemic Lupus Erythematosus, Lupus Nephritis (LN), Sjogren's Syndrome","enrollment":18},{"nctId":"NCT03331380","phase":"NA","title":"Technical Development of Cardiovascular Magnetic Resonance Imaging (CMR) Using a Low Specific Absorption Rate (SAR) Scanner System","status":"RECRUITING","sponsor":"National Heart, Lung, and Blood Institute (NHLBI)","startDate":"2018-01-05","conditions":"CAD","enrollment":2950},{"nctId":"NCT05894512","phase":"","title":"Analysis of T- and B-Cell Subpopulations in Membranous Nephropathy","status":"COMPLETED","sponsor":"Istanbul University","startDate":"2023-06-01","conditions":"Membranous Nephropathy, Membranous Nephropathy - PLA2R Induced, Membranous Nephropathy - THSD7A Induced","enrollment":44},{"nctId":"NCT06975878","phase":"PHASE3","title":"Study of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sanofi","startDate":"2025-05-22","conditions":"Pneumococcal Immunization, Healthy Volunteers","enrollment":1092},{"nctId":"NCT07104721","phase":"PHASE1","title":"A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases","status":"RECRUITING","sponsor":"China Immunotech (Beijing) Biotechnology Co., Ltd.","startDate":"2025-08-04","conditions":"Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN), Systemic Sclerosis (SSc)","enrollment":18},{"nctId":"NCT07441525","phase":"EARLY_PHASE1","title":"UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases","status":"RECRUITING","sponsor":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","startDate":"2026-02-03","conditions":"Autoimmune Hemolytic Anemia, Primary Immune Thrombocytopenic Purpura, Evans Syndrome","enrollment":27},{"nctId":"NCT01555892","phase":"PHASE1","title":"Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE","status":"RECRUITING","sponsor":"Baylor College of Medicine","startDate":"2013-01-14","conditions":"Hodgkin's Disease, Non-Hodgkin's Lymphoma, Lymphoproliferative Disease","enrollment":136},{"nctId":"NCT07444307","phase":"PHASE1","title":"A Clinical Study of Dual-Target, Universal CAR-T Cell Therapy for Refractory Systemic Lupus Erythematosus","status":"RECRUITING","sponsor":"Hangzhou Qihan Biotech Co., Ltd.","startDate":"2025-12-15","conditions":"Systemic Lupus Erythematosus (SLE)","enrollment":18},{"nctId":"NCT07441746","phase":"NA","title":"Clinical Implementation of the Group Standard for Enteral Feeding Care in Critically Ill Children","status":"NOT_YET_RECRUITING","sponsor":"Children's Hospital of Fudan University","startDate":"2026-03","conditions":"Clinical Implementation, Standardized Tube Feeding Care, Enteral Nutrition","enrollment":500},{"nctId":"NCT07169500","phase":"PHASE1, PHASE2","title":"Clinical Study on the Safety and Efficacy of BCMA-CART±ASCT in Treating Young Multiple Myeloma Patients","status":"RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2025-03-03","conditions":"Multiple Myeloma","enrollment":50},{"nctId":"NCT07236801","phase":"PHASE1","title":"Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases","status":"RECRUITING","sponsor":"China Immunotech (Beijing) Biotechnology Co., Ltd.","startDate":"2025-11-13","conditions":"Systemic Lupus Erythematosus (SLE), Systemic Sclerosis, Sjogren's Syndrome (SS)","enrollment":18},{"nctId":"NCT07123519","phase":"PHASE1","title":"A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases","status":"RECRUITING","sponsor":"China Immunotech (Beijing) Biotechnology Co., Ltd.","startDate":"2025-08-13","conditions":"Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN), Sjogren's Syndrome (SS)","enrollment":18},{"nctId":"NCT06474676","phase":"PHASE1","title":"T Cell Membrane-Anchored Tumor-Targeted IL12 -Modified TIL Cell Therapy (attIL12-TIL) for Advanced/Metastatic Soft Tissue and Bone Sarcoma Patients.","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2025-09-29","conditions":"Metastatic Soft-tissue Sarcoma","enrollment":40},{"nctId":"NCT07058194","phase":"NA","title":"Effect of Pre- and Postoperative ESP Block on Frontal QRS-T Angle in Laparoscopic Cholecystectomy","status":"COMPLETED","sponsor":"Harran University","startDate":"2025-07-20","conditions":"Cholecystectomy, Laparoscopic, Pain, Postoperative, Electrocardiography","enrollment":135},{"nctId":"NCT07434765","phase":"NA","title":"Comparison of Outcomes of Conventional Septoplasty vs Conservative Endoscopic Septoplasty","status":"COMPLETED","sponsor":"Shahida Islam Medical Complex","startDate":"2025-11-18","conditions":"Deviated Nasal Septum","enrollment":210},{"nctId":"NCT07441291","phase":"PHASE3","title":"CD19 CAR-T vs DLI for Post-HSCT MRD in Ph- ALL: A RCT","status":"RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2025-11-30","conditions":"B ALL, Allogenetic Hematopoietic Stem Cell Transplantation, MRD-positive","enrollment":70},{"nctId":"NCT02291848","phase":"PHASE1","title":"Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma","status":"RECRUITING","sponsor":"Baylor College of Medicine","startDate":"2015-04","conditions":"Multiple Myeloma","enrollment":36},{"nctId":"NCT07434284","phase":"EARLY_PHASE1","title":"Exploratory Clinical Study of cCTL in Combination With Immunotherapy for Advanced Gynecologic Malignancies","status":"RECRUITING","sponsor":"Obstetrics & Gynecology Hospital of Fudan University","startDate":"2026-02","conditions":"Advanced Gynecological Cancers","enrollment":20},{"nctId":"NCT05234190","phase":"PHASE1, PHASE2","title":"Safety and Clinical Activity of QEL-001 in A2-mismatch Liver Transplant Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Quell Therapeutics Limited","startDate":"2022-01-21","conditions":"Rejection; Transplant, Liver, Liver Failure, Liver Diseases","enrollment":33},{"nctId":"NCT07399197","phase":"NA","title":"3-D Evaluation of Alveolar Bone Changes and Root Resorption After Traction of Buccally Displaced Maxillary Canines","status":"NOT_YET_RECRUITING","sponsor":"Sana'a University","startDate":"2026-03-02","conditions":"Malocclusion; Displaced Teeth","enrollment":40},{"nctId":"NCT07414758","phase":"PHASE3","title":"Golidocitinib Versus Placebo as Maintenance Therapy in PTCL Patients With Response (CR/PR) After First-Line Chemotherapy","status":"RECRUITING","sponsor":"Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine","startDate":"2026-02-15","conditions":"Peripheral T Cell Lymphoma","enrollment":68},{"nctId":"NCT05997264","phase":"PHASE2","title":"Anthrax AV7909 Boost Evaluation Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Biomedical Advanced Research and Development Authority","startDate":"2023-12-05","conditions":"Anthrax","enrollment":220},{"nctId":"NCT07429461","phase":"EARLY_PHASE1","title":"Clinical Study of SYNCAR-100 in the Treatment of Relapsed/Refractory Acute B-Lymphoblastic Leukemia","status":"RECRUITING","sponsor":"Zhejiang University","startDate":"2026-02-28","conditions":"B-Cell Acute Lymphoblastic Leukemia","enrollment":16}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":4952,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["vaccine made by Beijing Minhai Biotechnology Co., Ltd"],"phase":"marketed","status":"active","brandName":"Group T","genericName":"Group T","companyName":"Bursa Yuksek Ihtisas Training and Research Hospital","companyId":"bursa-yuksek-ihtisas-training-and-research-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Group T works by inhibiting the action of a specific enzyme. Used for Hypertension.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}